Xeris Biopharma Holdings, Inc. (XERS) Q1 2026 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good morning and welcome to the Xeris Biopharma Q126 Earnings Conference Call. Please note that before we begin, this conference is being recorded on Thursday, May 7th at 8.30 a.m. I will now pass the call over to Alison Wei for opening remarks. Please go ahead. Thank you, Sarah. Good morning, everyone, and welcome to Xeris' first quarter financial results conference call. Earlier this morning, we issued a press release detailing our first quarter 2026 financial and operating results. This press release can be found on our website. Joining me today is John Shannon, our Chief Executive Officer, and Steve Piper, our Chief Financial Officer. Following our prepared remarks, we will open the call for your questions. Before we begin, I'd like to remind you that today's discussion will include forward-looking statements regarding Xeris's future expectations, plans, strategies, objectives, and financial performance. These forward-looking statements are based on management's current assumptions and beliefs and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those expressed or implied. For discussion of these risks and uncertainties, please refer to the risk factors described in our filings with the SEC. Any forward-looking statements made on this call speak only as of today's date. And except as required by law, the company undertakes no obligation to update or revise these statements. In addition, during today's call, we will reference certain financial measures that are represented on a non-GAAP basis. A reconciliation of these non-GAAP measures to the most directly comparable GAAP measures is included in our press release. With that, I will now turn the call over to John for his opening remarks. Thank you and goo...